RSC Pharmaceutics – first articles now online

Explore the first articles from RSC Pharmaceutics

We are delighted to share the first articles from RSC Pharmaceutics. Our new journal publishes crucial research on pharmaceutics, which has the potential to drive real change in worldwide health. Every article is gold open access, so you can read and be inspired for free.

Dextrin conjugation to colistin inhibits its toxicity, cellular uptake and acute kidney injury in vivo

Mathieu Varache, Siân Rizzo, Edward J. Sayers, Lucy Newbury, Anna Mason, Chia-Te Liao, Emilie Chiron, Nathan Bourdiec, Adam Jones, Donald J. Fraser, Philip R. Taylor, Arwyn T. Jones, David W. Thomas and Elaine L. Ferguson

RSC Pharm., 2024, Advance Article,
DOI: 10.1039/D3PM00014A

Indocyanine green within glycosylated polymeric micelles as potential image agents to map sentinel lymph nodes and breast cancer

Nicole Lecot, Marcelo Fernández-Lomónaco, Hugo Cerecetto, Juan Pablo Gambini, Pablo Cabral and Romina Glisoni

RSC Pharm., 2024, Advance Article,
DOI: 10.1039/D3PM00053B

A zuranolone nanocrystal formulation enables solubility-independent in vivo study of pentylenetetrazol-induced seizures in a rat model

Stanislav Chvíla, Hana Kubová, Pavel Mareš, Eva Kudová and František Štěpánek

RSC Pharm., 2024, Advance Article,
DOI: 10.1039/D3PM00043E

These articles and our future publications are free to access by anyone.

Start reading now

RSC Pharmaceutics provides researchers with a platform to publish research in pharmaceutics and advance this field. We are interested in any submission that shares new scientific findings across chemistry, materials science, biomedical sciences, pharmaceutics and drug delivery.

Sign up for email alerts and submit your manuscript.